July 30, 2008 – BrachySciences will distribute the AnchorSeed for prostate brachytherapy now with a second isotope, TheraSeed palladium-103, offering physicians the option of utilizing AnchorSeed with the two most commonly used isotopes for prostate brachytherapy, iodine-125 and palladium-103.
AnchorSeed’s patent pending design is intended to give existing low dose rate prostate brachytherapy sources the ability to maintain their position within tissue, thereby allowing physicians to confidently place seeds in more strategic and beneficial locations than in the past. It is designed for use both with Mick Applicators as well as with pre-loaded needles.
Utilizing a bioabsorbable polymer as in BrachySciences’ portfolio of strand products, AnchorSeed’s design reportedly offers an anchoring effect to help significantly reduce seed misalignment and seed migration. This ability to better maintain its position now allows physicians to place seeds where they may have hesitated in the past.
For more information: www.brachysciences.com